CRGN

Curagen Corp. (MM) (CRGN)

Curagen Corp. (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CRGN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2009/10/02	19:02	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/10/02	05:28	Edgar (US Regulatory)	(25-NSE)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/10/02	03:29	Business Wire	Celldex Therapeutics Announces Completed Acquisition of CuraGen Corporation	NASDAQ:CRGN	Curagen Corp. (MM)
2009/10/01	07:00	Business Wire	Celldex and CuraGen Stockholders Approve Acquisition of CuraGen Corporation	NASDAQ:CRGN	Curagen Corp. (MM)
2009/09/26	05:33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/09/26	02:33	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/09/03	19:01	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/08/29	06:27	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/08/18	05:50	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/08/11	00:59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/08/06	03:03	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/08/01	03:35	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/08/01	03:33	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/07/31	19:00	PR Newswire (US)	CuraGen Reports Second Quarter 2009 Financial Results	NASDAQ:CRGN
2009/06/23	06:07	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/06/20	02:45	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/06/19	02:43	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/06/17	19:30	PR Newswire (US)	CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer	NASDAQ:CRGN	Curagen Corp. (MM)
2009/06/11	06:02	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/06/10	04:22	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/06/04	04:42	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/06/02	19:30	PR Newswire (US)	CuraGen Updates CR011-vcMMAE Data at ASCO	NASDAQ:CRGN	Curagen Corp. (MM)
2009/05/30	06:26	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/05/30	06:24	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/05/30	05:50	Edgar (US Regulatory)	Filing of certain prospectuses and communications in connection with business combination transactions (425)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/05/30	05:35	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/05/30	05:33	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:CRGN	Curagen Corp. (MM)
2009/05/29	19:54	Business Wire	Celldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen Corporation	NASDAQ:CRGN	Curagen Corp. (MM)
2009/05/28	19:30	PR Newswire (US)	CuraGen to Present CR011-vcMMAE Data at ASCO	NASDAQ:CRGN	Curagen Corp. (MM)
2009/05/20	04:15	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NASDAQ:CRGN	Curagen Corp. (MM)